15 December 2015
\n \n \n \nThe success rate of Assisted Reproductive Technology (ART) hovers around 30%. Even in successful cases, the incidence of multiple births, due to multiple embryo transfer, and their associated morbidity, is dangerously high. Now a new paper reveals how laser technology is being used to make ART safer and more efficient.
\n \n\n \n \n9 November 2015
\n \n \n \nThe link between chronic pain that affects millions of women and hormones that control the menstrual cycle and reproductive function is to be studied for the first time by researchers at the Nuffield Department of Obstetrics & Gynaecology.
\n \n\n \n \n5 May 2015
\n \n \n \nThe 12th Conference of the European Society for Reproductive Immunology will be held at Magdalen College, Oxford from Monday 21st \u2013 Thursday 24th September 2015
\n \n\n \n \n6 March 2015
\n \n \n \nWhat innovative therapies are there for Endometriosis - a condition that affects up to 10% of women during their reproductive life span, causing severe pelvic pain and reduced fertility.
\n \n\n \n \n28 January 2015
\n \n \n \nWhen assessing and planning treatment for women with chronic pelvic pain, a condition affecting more than one million women in the UK, the key role of the central nervous system must be considered.
\n \n\n \n \n16 November 2014
\n \n \n \nIt was in October 1978, 36 years ago, that the world\u2019s first 'test tube' baby was born, in Manchester. Consultant gynaecologist Patrick Steptoe and research physiologist Robert Edwards were pioneering the technique.
\n \n\n \n \n13 October 2014
\n \n \n \nDrs Suzannah Williams and Dagan Wells explore the secrets and processes behind human fertilisation. Sperm and eggs must face huge challenges before they even meet. After fertilisation, they go on to form a small ball of cells with huge potential.
\n \n\n \n \n24 July 2014
\n \n \n \nThe University of Oxford and Bayer HealthCare have entered into a strategic research alliance in the area of gynaecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. The alliance is for an initial period of two years, but is open for extension to up to five years.
\n \n\n \n \n25 November 2011
\n \n \n \nA new technique for screening embryos for genetic defects during IVF more than doubles the chances that the embryo will implant in the mother's womb
\n \n\n \n \n23 September 2011
\n \n \n \nThe test aims to reveal which of the embryo created using IVF has the best chance of making a baby, allowing these embryos to be given top priority for transfer to the uterus.\r\n
\n \n\n \n \n17 July 2011
\n \n \n \nThe brain imaging study carried out at Oxford University shows that period pain is associated with differences in the way the brain processes pain, and that these differences persist throughout a woman\u2019s menstrual cycle.
\n \n\n \n \n13 July 2011
\n \n \n \nThe test avoids the need to manipulate and biopsy the egg itself and may also shed light on the crucial role played by certain genes in the development of chromosome abnormalities that are a major cause of miscarriages and conditions such as Down\u2019s syndrome.
\n \n\n \n \n17 October 2010
\n \n \n \nThe research identifies two genetic variants that increase the risk of developing Endometriosis, a common gynaecological disease and provides clues to the origin of this often very painful condition, which has a significant impact on the quality of life of sufferers.
\n \n\n \n \n